| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5665753 | Current Opinion in Immunology | 2017 | 9 Pages |
â¢Memory T cells have quiescent metabolism.â¢Activation of T cells triggers both glycolysis and oxidative phosphorylation.â¢Elevated T cell metabolic activity is necessary at the tumor site to promote tumor killing.â¢High mitochondrial membrane potential (ÎΨm) is associated with cytokine production and capacity for cytotoxic function.â¢Metabolic reprogramming of T cells may improve TCR and chimeric antigen receptor (CAR) based immunotherapy.
Immunotherapies designed to trigger T cell destruction of tumor cells can result in sustained and complete responses in patients whose cancers were resistant to available treatment options. Evidence suggests that powering the T cell response - how T cells generate energy - plays an important role in their effectiveness. Furthermore the metabolism of T cells can be modulated to improve their anti-cancer activities. In this review, we will discuss the key metabolic properties of anti-cancer T cells, along with potential strategies to enhance immunotherapy through the modulation of T cell metabolism.
